Navigation Links
Volcano Receives FDA Clearance to Market the Eagle Eye(R) Platinum Digital IVUS Catheter
Date:2/9/2010

SAN DIEGO, Feb. 9 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Eagle Eye® Platinum digital IVUS catheter in the United States. This state-of-the-art catheter offers all of the benefits of the predecessor Eagle Eye® Gold catheter, plus improved deliverability and the convenience of additional radiopaque markers. Commercial release of Eagle Eye® Platinum in the U.S. is expected in the second quarter of 2010.

"Multiple studies have shown the benefits of IVUS imaging," commented Scott Huennekens, President and Chief Executive Officer of Volcano. "With Eagle Eye® Platinum, we're now providing clinicians further improvements to our industry-leading catheter design. Despite the fact that our customers have made Eagle Eye® Gold the #1 selling IVUS catheter in the United States, we recognize the need to continuously improve our products to support the treatment of the increasingly challenging blockages or lesions interventional cardiologists are addressing. Our investments in advanced catheter design have resulted in the Eagle Eye® Platinum, a product that has enhanced deliverability, is significantly easier to use, and includes Volcano's proprietary VH® IVUS tissue characterization technology, a unique imaging modality that is backed by 15 years of research and data published in over 100 articles, and has been studied in over 10,000
'/>"/>

SOURCE Volcano Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Volcano Corporation Completes Acquisition of Lumen Biomedicals Xtract(TM) Thrombus Aspiration Catheter
2. Volcano Corporation Announces Litigation Status
3. Volcano Corporation Announces Preliminary Record Revenues for Fourth Quarter 2009; Total Year Revenues are Expected to Exceed Prior Guidance
4. Volcano Corporation Commends the Elevation of FFR to Level of Evidence A in New PCI Guidelines
5. Volcano Announces Installed Base Growth Milestone
6. Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging
7. Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast
8. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
9. Volcanos VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKlines Novel Investigational Compound, Darapladib
10. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
11. Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015  Results of the ... Consecutive Cases Using MarginProbe for Intra-Operative Positive Margin Detection ... session at the 32 nd Annual Miami Breast ... conducted by Moshe Papa , MD, FACS, Professor ... Tel Aviv University, reports an analysis of MarginProbe,s efficiency ...
(Date:3/4/2015)... 2015  Bayer HealthCare today announced that the ... the company,s Biologics License Application (BLA) for BAY ... seeking FDA approval of the investigational compound, proposed ... A in children and adults. ... to hemophilia A patients who need them," said ...
(Date:3/4/2015)... -- Heska Corporation (Nasdaq: HSKA ) announces the ... Fourth Quarter and Year End 2014 Earnings Conference Call ... (MST) / 11:00 a.m. (EST)Where: www.heska.com (click on ... on the front page of this website)How:Live over the ... the address above.  Alternatively, you may use the following ...
Breaking Medicine Technology:New Study Shows Breast Re-excision Rates Significantly Reduced in 100 Consecutive Cases 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 3Webcast Alert: Heska Announces Fourth Quarter and Year End 2014 Earnings Conference Call Webcast 2
(Date:3/4/2015)... 2015 The print component of “Organic ... Francisco Chronicle with a circulation of approximately 173,000 copies ... component is distributed nationally through a vast social media ... and partner outlets. To explore the digital version of ... is composed of heat-dried microbes that have digested the ...
(Date:3/4/2015)... The New Mel Brooks Musical Young ... be performed by the award-winning Drama Department of Peninsula ... 6-22, 2015, on Fridays, Saturdays and Sundays. Performances are ... (27118 Silver Spur Road, Rolling Hills Estates, CA ... or may be purchased on-line at https://sites.google.com/site/penhidrama . ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Columbus is no ... steady prevalence of cocaine addiction, and suffers from the ... on Feb. 27th, the DEA revealed that Kratom is ... a herbal tea; the newly introduced herb from Southeast Asia ... in heightened doses. WKYC notes kratom foments symptoms similar to ...
(Date:3/4/2015)... The Alliance for Regenerative Medicine ... upcoming fifth annual Advanced Therapies Summit next Thursday, ... this year will feature five expert-led interactive roundtables ... field’s leading companies and organizations. , This ... clinical researchers from the advanced therapies community across ...
(Date:3/4/2015)... Today Visiopharm announces that Patrik Dahlén, previously the ... Visiopharm Board of Directors as Chairman. Mr. ... positioned to become the fastest growing software company, specializing ... , "Over the last several years, Visiopharm ... ONCOtopix™ Dx, a complete quantitative digital pathology solution for ...
Breaking Medicine News(10 mins):Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2Health News:Columbus, OH Combats the Sale of Kratom as a Drug, Harbor Village Detox Stresses Caution 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 3Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 2Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 3
... acupuncture in women with cystitis depends upon how their ... is an inflammation of the bladder which leads to ... burning pain when urinating. It's common among women and ... ,Terje Alraek of the University of Bergen, Norway, describes ...
... to a recent study it is observed that a molecular ... research today, there is increasing emphasis on looking for molecules// ... progression of the disease. Scientists at New York University now ... be important in tracking melanoma, the most serious form of ...
... an effective utility tool to the field of medicine. ... decisions about their treatment. The days when doctors told ... today expect to participate in the decision-making process. But ... conflicting messages and new research comes up all the ...
... proposes that having a good coping style helps women to ... whether mental attitude makes a difference in the fight against ... studies and they conclude that stress, mental outlook and coping ... function and hormonal levels. ,They found that up ...
... younger people remember important events in detail, older people ... that memory changes with age - some researchers believe ... in a different way. Psychologists in Toronto have been ... like their first kiss. ,They studied a ...
... to new research from Albert Einstein College of ... tool that may help them predict who will develop ... from Albert Einstein College of Medicine finds the presence ... predicts the risk of developing dementia. The form of ...
Cached Medicine News:
... Pool punctum plugs. Tear Pool punctum plugs are ... no additives via a precision molding process. The ... is designed to facilitate insertion as well as ... in the punctum. The cap of the plug ...
... Terason's background in high performance ... the field of echocardiography. Echocardiography imaging ... rates, and sensitive Doppler performance. The ... Terason's proprietary Teratech Architecture, delivers a ...
... When myocardial infarction is ... TROPT sensitive rapid assay allows ... marker troponin T from a ... qualitative result is available within ...
... increase in Endoscopic cases it is extremely popular ... the Surgical Light. This combination affords the ... to adopt an uncomfortable pose. The Dual ... NUVO Monitoring System. As such the light ...
Medicine Products: